Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Current Drug Metabolism|October 21, 2016
E-MHK-0103 (Mineraxin™): A Novel Nutraceutical with Biological Properties in Menopausal ConditionsLola Corzo, Susana Rodriguez, Ramon Alejo, et al.
Neurological Research|September 25, 2003
Cerebrovascular risk factors in Alzheimer's disease: brain hemodynamics and pharmacogenomic implicationsRamón Cacabelos, Lucía Fernández-Novoa, Valter Lombardi, et al.
Nutrients|March 15, 2020
Nutrition, Health, and Disease: Role of Selected Marine and Vegetal NutraceuticalsLola Corzo, Lucía Fernández-Novoa, Iván Carrera, et al.
Neurological Research|July 22, 2004
Phenotypic profiles and functional genomics in Alzheimer's disease and in dementia with a vascular componentRamón Cacabelos, Lucía Fernández-Novoa, Lola Corzo, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2022
Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and DevelopmentRamón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, et al.
Life (Basel, Switzerland)|March 25, 2022
Personalized Management and Treatment of Alzheimer's DiseaseRamón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, et al.
Current Pharmaceutical Biotechnology|November 30, 2011
Genomics and pharmacogenomics of brain disordersRamon Cacabelos, Rocio Martinez-Bouza, Juan Carlos Carril, et al.
International Journal of Molecular Sciences|March 16, 2019
Sirtuins in Alzheimer's Disease: SIRT2-Related GenoPhenotypes and Implications for PharmacoEpiGeneticsRamón Cacabelos, Juan C Carril, Natalia Cacabelos, et al.
Pharmacogenomics|January 11, 2023
Pharmacogenetics of anxiety and depression in Alzheimer's diseaseRamón Cacabelos, Juan C Carril, Lola Corzo, et al.
CNS & Neurological Disorders Drug Targets|February 3, 2016
Novel Therapeutic Strategies for DementiaRamón Cacabelos, Clara Torrellas, Iván Carrera, et al.
Pageof 3